Dr. Perry Kimball Richardson, MD

Dr. Richardson practices at Medical Faculty Associates, Inc in Washington, District of Columbia.

Dr. Richardson's NPI, 1427022086, was assigned on February 13, 2006. Dr. Richardson graduated from George Washington University School of Medicine and Health Sciences in 1984. Dr. Richardson holds District of Columbia license D21085.

Dr. Richardson's primary practice is Medical Faculty Associates, Inc, at 2150 Pennsylvania NW Ave, Washington, DC 20037 in District Of Columbia County. The practice phone is (202) 741-3350.

Dr. Richardson's primary practice is Medical Faculty Associates, Inc in Washington, District of Columbia. Dr. Richardson is also affiliated with The George Washington University Hospital. The medical group on file is The GW Medical Faculty Associates. Dmand AI also links Dr. Richardson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Richardson practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Richardson's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Richardson is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Richardson's licenses on file in 4 states: District of Columbia, Virginia, Maryland and Illinois.

Dmand AI lists carpal tunnel syndrome, hereditary polyneuropathy, lower back pain, migraine and chronic headache, mobility impairment, multiple sclerosis, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Richardson treats.

CMS data shows 15,992 Medicare services from Dr. Richardson across 17 procedure codes in 2024, for 250 Medicare patients. Medicare paid $139,257 for them.

CMS counts 250 Medicare patients who saw Dr. Richardson in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 31% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Richardson's median patient age at 58, with 60% women.

In 2024, Dr. Richardson wrote 356 Medicare Part D claims for 64 patients. 74% of them were for generic drugs. CMS names the drug for 223 of them, across 13 drugs with 11 or more claims each, at $342,072 in total drug cost. In 2023, CMS named 221 claims across 13 drugs.

Dr. Richardson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Richardson, published from 2013 to 2021. 2020 was the busiest year, with 2. The most frequent topics are Median Nerve, Nervous System Diseases and Cauda Equina. Dr. Richardson has published most often in Muscle Nerve. Dr. Richardson's most frequent co-authors are Ahmet Z. Burakgazi, MD, Elham Bayat, MD and Mohammad A. Abu-Rub, MBBS.

Dmand AI links Dr. Richardson to 1 clinical trial. Conditions studied include Stevens-Johnson Syndrome and Erythema Multiforme.

CMS Open Payments shows 224 general payments to Dr. Richardson from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $54,686.

Dmand AI lists 18 awards for Dr. Richardson, most recently Certificate of Appreciation in 2014.

Dr. Richardson graduated from George Washington University School of Medicine and Health Sciences in 1984. Dr. Richardson is a member of AOA, AAN, AANEM and Association of Universtiy Professors of Neurology.

Dr. Richardson is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.